p53 and Ki-ras as prognostic factors for Dukes' stage B colorectal cancer
- 1 May 2000
- journal article
- Published by Elsevier in European Journal Of Cancer
- Vol. 36 (8) , 1008-1015
- https://doi.org/10.1016/s0959-8049(00)00036-8
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- Kirsten ras Mutations in Patients With Colorectal Cancer: the Multicenter "RASCAL" StudyJNCI Journal of the National Cancer Institute, 1998
- PROGNOSTIC SIGNIFICANCE OF p53 ABNORMALITIES IN COLORECTAL CARCINOMA DETECTED BY PCR-SSCP AND IMMUNOHISTOCHEMICAL ANALYSISThe Journal of Pathology, 1996
- Concordance between p53 protein overexpression and gene mutation in a large series of common human carcinomasHuman Pathology, 1996
- ras and p53 in the prediction of survival in Dukes' stage B colorectal carcinomaMolecular Pathology, 1995
- Evaluation of p53 protein expression as a marker for long-term prognosis in colorectal carcinomaBritish Journal of Cancer, 1995
- The common molecular genetic alterations in Dukes' B and C colorectal carcinomas are not short‐term prognostic indicators of survivalInternational Journal of Cancer, 1994
- Prognostic factors in colorectal cancerBritish Journal of Surgery, 1992
- The p53 tumour suppressor geneNature, 1991
- PREDICTION OF OUTCOME AFTER CURATIVE RESECTION FOR LARGE BOWEL CANCERThe Lancet, 1986
- Histological Grading of Rectal CancerProceedings of the Royal Society of Medicine, 1937